COG7 Antibody (C-term)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| WB, E |
---|---|
Primary Accession | P83436 |
Other Accession | NP_705831.1 |
Reactivity | Human, Mouse |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 86344 Da |
Antigen Region | 725-753 aa |
Gene ID | 91949 |
---|---|
Other Names | Conserved oligomeric Golgi complex subunit 7, COG complex subunit 7, Component of oligomeric Golgi complex 7, COG7 |
Target/Specificity | This COG7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 725-753 amino acids from the C-terminal region of human COG7. |
Dilution | WB~~1:1000 E~~Use at an assay dependent concentration. |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | COG7 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | COG7 |
---|---|
Function | Required for normal Golgi function. |
Cellular Location | Golgi apparatus membrane; Peripheral membrane protein |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
The protein encoded by this gene resides in the golgi, and constitutes one of the 8 subunits of the conserved oligomeric Golgi (COG) complex, which is required for normal golgi morphology and localization. Mutations in this gene are associated with the congenital disorder of glycosylation type IIe.
REFERENCES
Zeevaert, R., et al. Eur J Med Genet 52(5):303-305(2009)
Laufman, O., et al. EMBO J. 28(14):2006-2017(2009)
Morava, E., et al. Eur. J. Hum. Genet. 15(6):638-645(2007)
Steet, R., et al. Mol. Biol. Cell 17(5):2312-2321(2006)
Shestakova, A., et al. Traffic 7(2):191-204(2006)

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.